Exogenesis Corporation is a privately-held, venture capital backed company developing and commercializing proprietary nanoscale surface modification and surface control technologies which have application in improving the safety and efficacy of implantable medical devices and improving the performance of optics, glass and a variety of substrates used in the laser, memory and semiconductor industries.Continue Reading →
The Exogenesis technology has the unique ability to produce important atomic level surface modification effects without coatings or additives.
The NanoAccelTM Gas Cluster Ion Beam (GCIB) technology was originally developed to provide nanoscale surface processing of semiconductors and other opto-electronic devices. Exogenesis acquired the exclusive worldwide rights to GCIB intellectual property for biomedical applications and has subsequently developed a complementary particle beam processing technology called NanoAccel Accelerated Neutral Atom Beam (ANAB).
Continue Reading →